Gruss Capital Management’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-4,586,200
Closed -$2.43M 16
2018
Q3
$2.43M Sell
4,586,200
-913,800
-17% -$490K 0.34% 16
2018
Q2
$2.75M Hold
5,500,000
0.29% 23
2018
Q1
$2.32M Hold
5,500,000
0.23% 26
2017
Q4
$2.09M Hold
5,500,000
0.17% 19
2017
Q3
$1.98M Hold
5,500,000
0.17% 21
2017
Q2
$2.09M Hold
5,500,000
0.17% 25
2017
Q1
$2.48M Hold
5,500,000
0.18% 29
2016
Q4
$2.09M Hold
5,500,000
0.05% 41
2016
Q3
$1.49M Hold
5,500,000
0.04% 41
2016
Q2
$1.32M Hold
5,500,000
0.04% 29
2016
Q1
$627K Hold
5,500,000
0.02% 51
2015
Q4
$619K Hold
5,500,000
0.02% 79
2015
Q3
$1.05M Buy
5,500,000
+1,500,000
+38% +$510K 0.03% 77
2015
Q2
$2.8M Hold
4,000,000
0.1% 57
2015
Q1
$2.71M Hold
4,000,000
0.11% 55
2014
Q4
$3.16M Sell
4,000,000
-4,425,000
-53% -$3.02M 0.09% 64
2014
Q3
$3.92M Hold
8,425,000
0.18% 47
2014
Q2
$4.21M Buy
8,425,000
+925,000
+12% +$447K 0.2% 47
2014
Q1
$2.4M Buy
7,500,000
+2,500,000
+50% +$929K 0.15% 46
2013
Q4
$1.7M Buy
5,000,000
+2,407,800
+93% +$2.91M 0.13% 50
2013
Q3
$5.24M Hold
2,592,200
0.51% 29
2013
Q2
$5M Buy
+2,592,200
New +$4.55M 0.54% 26

Other funds holding GCVRZ

Gruss Capital Management's GCVRZ Position: Q4 2018 in Review

Gruss Capital Management sold out of Sanofi Contingent Value Rights (GCVRZ) in Q4 2018, closing a stake of 4,586,200 shares — an estimated $2.43M sold.

Gruss Capital Management first reported a position in GCVRZ in Q2 2013 and held it in 22 quarters. The position peaked at $5.24M in Q3 2013. 103 funds tracked by Wall St. Rank hold GCVRZ as of Q4 2018.

  • Gruss Capital Management reported no remaining Sanofi Contingent Value Rights position as of Q4 2018 after selling out during the quarter.
  • Gruss Capital Management sold 4,586,200 Sanofi Contingent Value Rights shares in Q4 2018, an estimated $2.43M.
  • Gruss Capital Management first reported a position in Sanofi Contingent Value Rights in Q2 2013 and held it in 22 quarters.
  • Gruss Capital Management's Sanofi Contingent Value Rights position peaked at $5.24M in Q3 2013.
  • 103 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q4 2018.

Based on Gruss Capital Management's 13F filing for Q4 2018.